(Q36106785)

12 August 2017

1 reference

title

Pharmacotherapy of post-traumatic stress disorder: a family practitioners guide to management of the disease (English)

1 reference

post-traumatic stress disorder

12 August 2017

main subject

0 references

pharmacotherapy

0 references

author name string

Martin A Katzman

1

1 reference

12 August 2017

Lukasz Struzik

2

1 reference

12 August 2017

Lisa L Vivian

3

1 reference

12 August 2017

Monica Vermani

4

1 reference

12 August 2017

Joanna C McBride

5

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

129-139

1 reference

Posttraumatic stress disorder in the National Comorbidity Survey

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

'Subthreshold' mental disorders. A review and synthesis of studies on minor depression and other 'brand names'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Sertraline in the treatment of rape victims with posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Exposure to traumatic incidents and prevalence of posttraumatic stress symptomatology in urban firefighters in two countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Post-traumatic stress disorder among family physicians in Bosnia and Herzegovina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

PTSD among bereaved parents following the violent deaths of their 12- to 28-year-old children: a longitudinal prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

The prevalence of PTSD following the violent death of a child and predictors of change 5 years later.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Risk factors for long-term psychological effects of a disaster experienced in adolescence: predictors of post traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Implications of recent findings in posttraumatic stress disorder and the role of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Tolerability of fluoxetine in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

An open trial of citalopram in adolescents with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Open trial of citalopram in adults with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Fluvoxamine reduces physiologic reactivity to trauma scripts in posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Fluvoxamine and sleep disturbances in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Fluvoxamine treatment for chronic PTSD: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

A controlled trial of phenelzine in posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Open trial of nefazodone for combat veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Bupropion treatment in veterans with posttraumatic stress disorder: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Lithium for irritability in post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Gabapentin and Posttraumatic Stress Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Quetiapine therapy for posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Pilot study of secondary prevention of posttraumatic stress disorder with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Delayed-Onset Posttraumatic Stress Disorder: A Prospective Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.129

21 January 2018

Identifiers

DOI

10.1586/14737175.5.1.129

1 reference

12 August 2017

1 reference